Genprex Inc. (GNPX)
Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
Alvotech announces planned CEO succession and leadership transition
Alvotech tilkynnir breytingar á yfirstjórn félagsins
Alvotech announces planned CEO succession and leadership transition
Cartesian Therapeutics Announces New Employment Inducement Grants
Ionis to present at 44th Annual J.P. Morgan Healthcare Conference
Viridian Therapeutics, Inc. - Viridian Therapeutics Prepares for Transformational 2026
Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Viridian Therapeutics Prepares for Transformational 2026